Table 3 The associations between WWI and sarcopenia.
Model 1 [OR (95% CI)] | Model 2 [OR (95% CI)] | Model 3 [OR (95% CI)] | |
|---|---|---|---|
Male | |||
WWI (continuous) | 15.50 (13.69, 17.56) < 0.0001 | 15.75 (13.66, 18.15) < 0.0001 | 14.55 (12.33, 17.15) < 0.0001 |
WWI (quartile) | |||
Q1(8.23–10.21) | Reference | Reference | Reference |
Q2(10.21–10.75) | 9.92 (3.95, 24.93) < 0.0001 | 6.53 (2.60, 16.44) < 0.0001 | 5.19 (2.06, 13.10) 0.0005 |
Q3(10.75–11.26) | 64.08 (26.44, 155.31) < 0.0001 | 36.34 (14.94, 88.36) < 0.0001 | 24.96 (10.20, 61.05) < 0.0001 |
Q4(11.26–13.83) | 424.74 (176.19, 1023.93) < 0.0001 | 225.59 (93.05, 546.91) < 0.0001 | 124.79 (50.89, 305.99) < 0.0001 |
P for trend | < 0.0001 | < 0.0001 | < 0.0001 |
Female | |||
WWI (continuous) | 4.47 (4.13, 4.85) < 0.0001 | 3.55 (3.25, 3.88) < 0.0001 | 2.86 (2.59, 3.15) < 0.0001 |
WWI (quartile) | |||
Q1(7.90–10.42) | Reference | Reference | Reference |
Q2(10.42–11.00) | 3.78 (2.67, 5.36) < 0.0001 | 2.81 (1.98, 4.00) < 0.0001 | 2.28 (1.60, 3.27) < 0.0001 |
Q3(11.00–11.60) | 9.45 (6.81, 13.11) < 0.0001 | 5.76 (4.13, 8.04) < 0.0001 | 3.86 (2.75, 5.43) < 0.0001 |
Q4(11.60–15.52) | 33.02 (24.05, 45.33) < 0.0001 | 16.51 (11.93, 22.86) < 0.0001 | 9.17 (6.54, 12.86) < 0.0001 |
P for trend | < 0.0001 | < 0.0001 | < 0.0001 |